UOWF
JANX icon

University of Wisconsin Foundation’s Janux Therapeutics JANX Stock Holding History

University of Wisconsin Foundation’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-362,000
Closed -$5M – 11
2025
Q4 		$5M Buy
+362,000
New +$8.51M 4.2% 8

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

University of Wisconsin Foundation's JANX Position: Q1 2026 in Review

University of Wisconsin Foundation sold out of Janux Therapeutics (JANX) in Q1 2026, closing a stake of 362,000 shares — an estimated $5M sold.

University of Wisconsin Foundation first reported a position in JANX in Q4 2025 and held it in 1 quarter. The position peaked at $5M in Q4 2025. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • University of Wisconsin Foundation reported no remaining Janux Therapeutics position as of Q1 2026 after selling out during the quarter.
  • University of Wisconsin Foundation sold 362,000 Janux Therapeutics shares in Q1 2026, an estimated $5M.
  • University of Wisconsin Foundation first reported a position in Janux Therapeutics in Q4 2025 and held it in 1 quarter.
  • University of Wisconsin Foundation's Janux Therapeutics position peaked at $5M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on University of Wisconsin Foundation's 13F filing for Q1 2026, filed 14 May 2026.